IRCT201209309645N2已完成未知
An open – label study of Aripiprazole in the treatment of irritability in children with autistic disorder
niversity of Social Welfare and Rehabilitation Sciences0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 years 至 6 years（—）
- 性别
- All
入选标准
- •clinical diagnosis of autism; ages 3-6 years
- •Exclusion criteria: use of antidepressants or antipsychotics one week before trial (fluoxetine 1 month before trial); use of psychostimulants or benzodiazepines 72 hours before trial; severe medical diseases; current diagnosis of bipolar disorder, psychosis,schizophrenia, major depression
排除标准
- 未提供
研究者
相似试验
已完成
2 期
An Open Label Study of the use of Aripiprazole in the Treatment of Chronic Post Traumatic Stress DisorderPost Traumatic stress DisorderMental Health - Other mental health disordersACTRN12605000322639Austin Health20
未知
3 期
ong-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients with Major Depressive DisorderMajor Depressive DisorderJPRN-jRCT2080220699Otsuka Pharmaceutical Co., Ltd.100
已完成
不适用
Observational study of the effect of aripiprazole on waking difficultyPatient being treated for depression with difficulty waking up for which aripiprazole was prescribedJPRN-UMIN000048309Kurume University School of Medicine12
未知
4 期
Post Marketing Clinical Study of Aripiprazole in Patients with Schizophrenia - Effects on Glucose MetabolismSchizophreniaJPRN-jRCT1080220320Otsuka Pharmaceutical Co., Ltd.
未知
3 期
A short treatment study of aripiprazole in pediatric patients with Autistic DisorderAutistic Disorder, children and adolescentsJPRN-jRCT2080221819Otsuka Pharmaceutical Co., Ltd.